Implementing an Evidence-based Alcohol Use and Sexual Risk Intervention in Young Adult Homeless Service Settings
NCT07933406, Phase 3, Not yet recruiting, RAND
Trial 10
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | Implementing an Evidence-based Alcohol Use and Sexual Risk Intervention in Young Adult Homeless Service Settings | ClinicalTrials.gov |
| NCT number | NCT07933406 | ClinicalTrials.gov |
| Status | Not yet recruiting | ClinicalTrials.gov |
| Phases | Phase 3 | ClinicalTrials.gov |
| Enrollment | 360 participants, estimated | ClinicalTrials.gov |
| Lead sponsor | RAND | ClinicalTrials.gov |
| Conditions | Alcohol Consumption, Alcohol Use Disorder (AUD), Substance Use (Drugs, Alcohol), Substance Use Disorder (SUD), Condomless Sex, Unprotected Sex, High-risk Sex | ClinicalTrials.gov |
| Interventions | AWARE | ClinicalTrials.gov |
| First posted | 2026-11-12 | ClinicalTrials.gov |
| Last updated | 2026-11-12 | ClinicalTrials.gov |
Registered outcomes 12
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | Alcohol use frequency | Baseline, 3 months, and 6 months follow-up | The number of alcohol use days (any alcohol use) and the number of binge drinking days (5+ drinks) in the past 30 days | ClinicalTrials.gov |
| Primary | Alcohol use quantity | Baseline, 3 months, and 6 months follow-up | The typical number of drinks consumed on drinking days, and the maximum number of drinks consumed on drinking days in the past 30 days | ClinicalTrials.gov |
| Primary | Alcohol use consequences | Baseline, 3 months, and 6 months follow-up | Number of alcohol consequences in the past 30 days, assessed by the Brief Young Adult Alcohol Consequences Questionnaire (BYAACQ) | ClinicalTrials.gov |
| Secondary | Other drug use frequency | Baseline, 3 months, and 6 months follow-up | Number of days of other drug use besides alcohol (cannabis, stimulants, opioids, sedatives/barbiturates, hallucinogens, cigarette and vape use) in the past 30 days. | ClinicalTrials.gov |
| Secondary | Cannabis use quantity | Baseline, 3 months, and 6 months follow-up | Amount of flower/bud consumed (in grams) on a typical cannabis use day | ClinicalTrials.gov |
| Secondary | Cannabis use consequences | Baseline, 3 months, and 6 months follow-up | Number of cannabis use consequences in the past 30 days, measured by the Brief-Marijuana Consequences Questionnaire (B-MACQ) | ClinicalTrials.gov |
| Secondary | Substance use disorder | Baseline, 3 months, and 6 months follow-up | Probable substance use disorder, measured with the Global Appraisal of Individual Needs Short Screener (GAIN-SS) | ClinicalTrials.gov |
| Secondary | Number of sexual partners | Baseline, 3 months, and 6 months follow-up | Number of oral, vaginal and anal sex partners in the past 3 months. Primary and casual sex partners will be reported separately. | ClinicalTrials.gov |
| Secondary | Condom use | Baseline, 3 months, and 6 months follow-up | Percentage of oral, vaginal, and anal sex events in which a condom was used in the past 3 months, assessed separately for primary and casual partners | ClinicalTrials.gov |
| Secondary | Alcohol or other drug use during sexual activity | Baseline, 3 months, and 6 months follow-up | Frequency of alcohol or other drug use before or during sex in the past 3 months (0=Never to 4=Every time), with primary and casual partners | ClinicalTrials.gov |
| Secondary | Perceived importance of condom use | Baseline, 3 months, and 6 months follow-up | Importance of increasing condom use during sex, or remaining a consistent condom user, measured on a scale from 0 (not at all important) to 10 (extremely important). | ClinicalTrials.gov |
| Secondary | Condom use self-efficacy | Baseline, 3 months, and 6 months follow-up | Self-efficacy to use a condom correctly and consistently and to discuss condom use with partners (from "not at all sure" to "very sure"), assessed using 8-items from a scale by Brafford and Beck (1991) | ClinicalTrials.gov |
Outcomes 0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 0
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 0
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|
Papers 4
The papers the trial lists on ClinicalTrials.gov.
Grants 0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years | Source |
|---|
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|
Source 5
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.4.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
| NIH clinical studies file | 2026-11-13 | ClinicalTrials.gov |
Release trials-2026-11-12-0.4.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)